Back
Comstock Resources 10K Form
Buy
60
CRK
Comstock Resources
Last Price:
$20.29
Seasonality Move:
2.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | CRK/Comstock Resources Quarterly |
2023-11-02 | 10Q | CRK/Comstock Resources Quarterly |
2023-08-03 | 10Q | CRK/Comstock Resources Quarterly |
2023-05-04 | 10Q | CRK/Comstock Resources Quarterly |
2022-11-03 | 10Q | CRK/Comstock Resources Quarterly |
2022-08-04 | 10Q | CRK/Comstock Resources Quarterly |
Receive CRK News And Ratings
See the #1 stock for the next 7 days that we like better than CRK
CRK Financial Statistics
Sales & Book Value
Annual Sales: | $1.3B |
---|---|
Cash Flow: | $174.7M |
Price / Cash Flow: | 8.78 |
Annual Sales: | $7.24 |
Price / Book: | 2.61 |
Profitability
EPS (TTM): | -1.11600 |
---|---|
Net Income (TTM): | $-323.7M |
Gross Margin: | $-130.1M |
Return on Equity: | -13.7% |
Return on Assets: | -5.07% |
Comstock Resources Earnings Forecast
Key Comstock Resources Financial Ratios
-
The Gross Profit Margin over the past 37 years for CRK is -10.37%.
-
The Selling, General & Administrative Expenses for CRK have been equal to 3.15% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of CRK is -17.45% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 17 years.
Comstock Resources Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | CRK |
CUSIP: | 205768 |
Website: | comstockresources.com |
Debt
Debt-to-Equity Ratio: | 1.44 |
---|---|
Current Ratio: | 0.4 |
Quick Ratio: | 0.28 |
Price-to-Earnings
Trailing P/E Ratio: | 24.92 |
---|---|
Forward P/E Ratio: | 14.72 |
CRK Technical Analysis vs Fundamental Analysis
Buy
60
Comstock Resources (CRK)
is a Buy
Is Comstock Resources a Buy or a Sell?
-
Comstock Resources stock is rated a BuyThe current Comstock Resources [CRK] share price is $18.87. The Score for CRK is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.